AbbVie (NYSE:ABBV) Q3 2026 Earnings Call
AbbVie (NYSE:ABBV) reports Q3 2026 results on this call. Live coverage runs here, and the full replay with transcript and chapters lands on this page after the call.
- Company
- AbbVie Inc. (NYSE:ABBV)
- Period
- Q3 2026 earnings call
- Date
- Fri, Oct 30, 2026, 9:00 AM ET
Latest news releases
- NYSE:ABBV — SKYRIZI® (risankizumab) and RINVOQ® (upadacitinib) Data Highlight Long-Term Clinical and Endoscopic Outcomes Across Inflammatory Bowel Disease (IBD) at UEGW 2026 · Sat, Oct 17, 2026
- NYSE:ABBV — AbbVie Presents New Phase 3 AFFIRM Data Showing Clinical and Endoscopic Outcomes With Subcutaneous SKYRIZI® (risankizumab-rzaa) in Patients With Moderately to Severely Active Crohn's Disease · Tue, Oct 13, 2026